Clinical Performance, Streptococcus Mutans Count, and Salivary pH for Cention-N, Zirconomer, and Resin-modified Glass Ionomer in Class I Restoration of Primary Molars
Evaluation of the Clinical Performance, Streptococcus Mutans Count, and Salivary pH for Cention-N, Zirconomer, and Resin-modified Glass Ionomer in Class I Restoration of Primary Molars: A Randomized Clinical Trial
研究概览
地位
条件
详细说明
A vital aspect of overall health is dental health. Recurrent effects of oral disease on eating, sleeping, working, and social duties are subtle and widespread, and they collectively form a hidden pandemic.
The most widely used substitute for amalgam is glass ionomer cement (GIC), which has recognized the capacity to produce fluoride and played a major role in their growing application in dentistry.
The components of resin-modified GICs (RMGIC) are the same as those of ordinary glass-ionomers: polyacid, water, and basic glass powder. A monomer component and related initiator system are also present. RMGICs were created when monomeric ingredients such as 2-hydroxyethyl methacrylate (HEMA), urethane dimethacrylate (UDMA), and bisphenol-A-glycidyl methacrylate (Bis-GMA) were added to the ionomer composition.
研究类型
注册 (估计的)
阶段
- 不适用
联系人和位置
学习联系方式
- 姓名:Galal A Elkady, B.Sc
- 电话号码:00201001375178
- 邮箱:dr_galal86@yahoo.com
学习地点
-
-
-
Cairo、埃及、11651
- 招聘中
- Al-Azhar University (Faculty of Dentistry)
-
副研究员:
- Adel F Hussein, MD
-
接触:
- Galal A Elkady, B.Sc
- 电话号码:00201001375178
- 邮箱:dr_galal86@yahoo.com
-
副研究员:
- Waleed O Kadour, MD
-
-
参与标准
资格标准
适合学习的年龄
- 孩子
接受健康志愿者
描述
Inclusion Criteria:
- Children aged between 4-9 years.
- Children who have Class I lesions in both the maxillary and mandibular arches.
- Primary molar teeth had class I carious lesions in occlusal pits and fissures; the gap between intercuspal surfaces should not be exceeded during cavity preparation.
- Primary molars free of periapical pathosis.
- Primary molars free root resorption.
Exclusion Criteria:
- Primary molars with preapical pathosis or hypersensitivity.
- Primary molars with periodontal diseases or mobile molar tooth that indicated for extraction.
- Nonfunctioning teeth with no opposing dentition; heavy occlusion or signs of severe attrition; and endodontically treated teeth.
学习计划
研究是如何设计的?
设计细节
- 主要用途:其他
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Group A
Primary molars with Class I cavity restoration using Cention-N material according to the manufacturer's instructions.
|
Class I cavity restoration using Cention-N self-curing resin-based dental restorative material according to the manufacturer's instructions.
|
|
实验性的:Group B
Primary molars with Class I cavity restoration using Zirconomer material according to the manufacturer's instructions
|
Class I cavity restoration using Zirconomer zirconia-reinforced glass ionomer restorative material according to the
|
|
有源比较器:Group C
Primary molars with Class I cavity restoration using Resin-Modified Glass Ionomer (RMGI) material according to the manufacturer's instructions
|
Class I cavity restoration using Resin-Modified Glass Ionomer (RMGI) restorative material according to the manufacturer's instructions
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Clinical Performance of Restorations
大体时间:6 months post-restoration
|
Evaluation of the clinical performance of restorations using modified USPHS (FDI) criteria.
It systematically grades how restorative materials (like composite resins, glass ionomers, and ceramics) perform in the mouth over time
|
6 months post-restoration
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Streptococcus Mutans Count
大体时间:6 months post-restoration
|
Assessment of Streptococcus mutans bacterial count in saliva/plaque samples expressed in CFU/mL will be recorded.
|
6 months post-restoration
|
|
Salivary pH Level
大体时间:6 months post-restoration
|
Salivary pH changes will be measured using a digital pH meter.
|
6 months post-restoration
|
合作者和调查者
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- 1021/3954
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
IPD 共享时间框架
IPD 共享访问标准
IPD 共享支持信息类型
- 研究方案
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.